🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/01/2017 | 152,30 | 153,48 | 151,43 | 153,00 | +0,26% | 1,35% | 987.000 |
| 20/01/2017 | 153,81 | 154,54 | 151,78 | 152,60 | -0,55% | 1,79% | 534.900 |
| 19/01/2017 | 152,93 | 154,84 | 151,04 | 153,44 | +0,42% | 2,48% | 632.100 |
| 18/01/2017 | 148,61 | 152,89 | 147,98 | 152,80 | +3,29% | 3,30% | 797.300 |
| 17/01/2017 | 149,50 | 149,80 | 147,37 | 147,94 | -1,52% | 1,63% | 490.700 |
| 13/01/2017 | 147,53 | 150,78 | 147,53 | 150,22 | +2,14% | 2,20% | 649.700 |
| 12/01/2017 | 142,50 | 147,34 | 141,86 | 147,07 | +3,00% | 3,85% | 726.200 |
| 11/01/2017 | 151,86 | 153,07 | 142,09 | 142,78 | -6,35% | 7,23% | 1.058.300 |
| 10/01/2017 | 148,78 | 152,66 | 147,32 | 152,46 | +3,11% | 3,59% | 706.800 |
| 09/01/2017 | 147,83 | 148,93 | 145,78 | 147,86 | +0,61% | 2,13% | 566.000 |
| 06/01/2017 | 146,98 | 148,75 | 146,10 | 146,96 | +0,73% | 1,80% | 489.900 |
| 05/01/2017 | 148,33 | 149,30 | 144,42 | 145,89 | -1,52% | 3,29% | 552.100 |
| 04/01/2017 | 144,61 | 149,09 | 143,84 | 148,14 | +2,88% | 3,63% | 646.200 |
| 03/01/2017 | 144,12 | 146,96 | 141,30 | 143,99 | +0,39% | 3,93% | 644.500 |
| 30/12/2016 | 144,50 | 145,40 | 142,65 | 143,43 | -0,35% | 1,90% | 528.400 |
| 29/12/2016 | 143,57 | 144,99 | 142,99 | 143,94 | +0,68% | 1,39% | 395.700 |
| 28/12/2016 | 143,81 | 144,99 | 141,95 | 142,97 | -0,39% | 2,11% | 407.100 |
| 27/12/2016 | 142,95 | 145,60 | 141,77 | 143,53 | +1,07% | 2,68% | 428.200 |
| 23/12/2016 | 139,85 | 142,88 | 139,40 | 142,01 | +1,84% | 2,49% | 509.700 |
| 22/12/2016 | 143,93 | 143,93 | 138,67 | 139,44 | -2,52% | 3,65% | 554.700 |
| 21/12/2016 | 145,06 | 145,55 | 142,48 | 143,04 | -1,61% | 2,12% | 518.700 |
| 20/12/2016 | 143,92 | 145,78 | 142,32 | 145,38 | +1,49% | 2,40% | 508.600 |
| 19/12/2016 | 145,19 | 147,60 | 142,58 | 143,24 | -0,90% | 3,46% | 567.800 |
| 16/12/2016 | 144,43 | 145,98 | 143,67 | 144,54 | -0,26% | 1,60% | 1.488.100 |
| 15/12/2016 | 140,19 | 145,50 | 139,44 | 144,92 | +4,95% | 4,32% | 784.400 |
| 14/12/2016 | 137,41 | 139,75 | 136,32 | 138,09 | +0,97% | 2,50% | 482.300 |
| 13/12/2016 | 139,05 | 139,64 | 135,24 | 136,76 | -1,58% | 3,16% | 579.800 |
| 12/12/2016 | 131,82 | 140,39 | 130,55 | 138,95 | +5,51% | 7,46% | 812.400 |
| 09/12/2016 | 132,72 | 136,49 | 131,45 | 131,69 | -0,14% | 3,80% | 400.900 |
| 08/12/2016 | 132,25 | 133,42 | 129,14 | 131,87 | +0,27% | 3,24% | 597.900 |